CLINICAL_TRIALS ClinicalTrials.gov record update

An Open Label Phase 2 Study to Evaluate PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03108066
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:11.198910+00:00
Published At: 2024-09-24T00:00:00+00:00
Record Updated At: 2024-09-24
Results Posted At: 2024-09-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["VHL Gene Mutation", "VHL", "VHL Syndrome", "VHL Gene Inactivation", "Von Hippel", "Von Hippel-Lindau Disease", "Von Hippel\u0027s Disease", "Von Hippel-Lindau Syndrome, Modifiers of", "Clear Cell Renal Cell Carcinoma", "Clear Cell RCC", "ccRCC"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-09-24"
protocolSection.identificationModule.nctId: "NCT03108066"
protocolSection.identificationModule.officialTitle: "An Open Label Phase 2 Study to Evaluate PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2024-09-24"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.